Orthopedic Use of BPC 157 Sports Med Review BREAKING FDA UPDATE MASSIVE FOR PEPTIDES The U.S. Food & Drug Administration is reportedly reclassifying 14 peptides from Category 2 ( compounding only, no legal prescribing) into Category 1. This means Industry Update: Interim 503A and 503B Bulks Lists New Revisions An important update for anyone following the peptide space. While these compounds are still under evaluation and not FDA approved, this shift signals growing momentum toward clinician guided peptide research. Stay informed, stay FDA Peptide Ban Lifted: Legit Compounding Pharmacies Now Regulate Julian Becerra posted on the topic LinkedIn